SciMatic
Journals
Docs
Products
SciMatic.net
Journament
Journal Manager
Subjects
Thesis
ImProofer
Research Groups
Letter Pad
Conferences
Services
API
About
SciMatic
Team
Earn With Us
Join Us
Contact Us
EN
English
Türkçe
Español
Português
Pусский
Filipino
Tiếng Việt
हिन्दी
العربية
বাংলা
Deutsch
中文
Login
international journal of antimicrobial agents
int j antimicrob agents
ISSN 1872-7913
663 views
Indexed In
ncbi
ulakbim
sci
Publications
23
ULAKBİM
MEP: 1.304
Ödeme: 6520
Yılı: 2020
Details
Abbreviated Name
int j antimicrob agents
ISSN
1872-7913
Publications/Year
Top Clicked Bibliographies from Search
18
Investigation into the selection frequency of resistant mutants and the bacterial kill rate by levofloxacin and ciprofloxacin in non-mucoid Pseudomonas aeruginosa isolates from cystic fibrosis patients
2002
422 clicks
16
The tcdA negative and tcdB positive Clostridium difficile ST81 clone exhibits high-level fluoroquinolone resistance: a multi-center study in Beijing, China.
2020
322 clicks
20
Epidemiology and antibiotic susceptibility of bacteria causing skin and soft tissue infections in the USA and Europe: a guide to appropriate antimicrobial therapy
2003
307 clicks
17
Susceptibility to fluoroquinolones among commonly isolated Gram-negative bacilli in 2000: TRUST and TSN data for the United States. Tracking Resistance in the United States Today. The Surveillance Network
2002
298 clicks
3
Risk factors of community-onset extended-spectrum β-lactamase-producing Klebsiella pneumoniae bacteremia in South Korea using National Health Insurance claims data.
2019
292 clicks
5
Antibacterial activity of griseofulvin analogs as example of drug repurposing.
2020
289 clicks
12
Cytokine storm and immunomodulatory therapy in COVID-19: role of chloroquine and anti-IL-6 monoclonal antibodies.
2020
286 clicks
11
BARICITINIB - A JANUASE KINASE INHIBITOR - NOT AN IDEAL OPTION FOR MANAGEMENT OF COVID 19.
2020
277 clicks
19
Multinational cooperation in trials and guidelines dealing with febrile neutropenia
2000
277 clicks
14
Hydroxychloroquine and azithromycin as a treatment of COVID-19: results of an open-label non-randomized clinical trial.
2020
259 clicks